For an imported new drug, it takes approximately 36-42 months from Investigational New Drug (IND) submission to New Drug Application (NDA) approval. (Click the image to download in full size.)
For more information about the pharmaceutical registration timeline and process in China, please see Pharmaceutical and API Product Registration in China.
You are welcome to use or share this infographic online or in your presentations and papers, as long as you include credits to Pacific Bridge Medical (www.pacificbridgemedical.com) and, if possible, a link back to the source.